Related Experiment Video
Updated: May 24, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Hypertension control and its association with left ventricular hypertrophy in children and young people on dialysis:
Gordon Bruce1, Ravsimrat Chawla1, Alexandra Savis1
1Department of Paediatric Nephrology, 3rd Floor Beckett House, Evelina London Children's Hospital, Guys & St Thomas' NHS Foundation Trust, Westminster Bridge Road, London, SE1 7EH, UK.
Insights
Hypertension in children on dialysis is linked to heart issues. Managing blood pressure and monitoring biomarkers like NT-proBNP may improve outcomes for pediatric dialysis patients.
Area of Science:
- Pediatric Nephrology
- Cardiology
- Hypertension Research
Background:
- Hypertension is a significant risk factor for adverse outcomes in children undergoing dialysis.
- Limited longitudinal data exist on ambulatory blood pressure monitoring (ABPM) and cardiac outcomes in pediatric dialysis patients.
Purpose of the Study:
- To investigate the relationship between ABPM, left ventricular hypertrophy (LVH), and cardiac outcomes in children and young people (CYP) initiating dialysis.
- To assess changes in LVH and LV mass over 12 months of dialysis treatment.
Main Methods:
- Retrospective, longitudinal study of 32 CYP (age 5-18) with paired echocardiogram and ABPM at baseline and 12-month follow-up.
- LVH defined by age-specific indexed left ventricular mass (LVMI) and LV mass-for-height z-score ≥ 95th percentile.
- Hypertension defined by ABPM ≥ 95th percentile; categorization included persistent hypertension, resolved hypertension, persistent normotension, or emergent hypertension.
Main Results:
- LVH prevalence decreased from 37.5% at baseline to 25% at follow-up, notably improving with hemodialysis but not peritoneal dialysis.
- Persistent hypertension in CYP was associated with higher rates of LVH and indexed LV mass at follow-up.
- Changes in LVMI were independently associated with baseline LVH and changes in N-terminal pro-brain b-type natriuretic peptide (NT-proBNP), suggesting a role for fluid overload.
Conclusions:
- Persistent hypertension in pediatric dialysis patients is linked to worse cardiac remodeling (LVH).
- The correlation between NT-proBNP and LVMI changes suggests fluid overload is a key factor.
- NT-proBNP may serve as a valuable biomarker for optimizing hypertension management in this population.
Background:
Hypertension remains one of the most prevalent modifiable risk associations for adverse outcomes in children receiving dialysis. Despite this, limited longitudinal data exist regarding ambulatory blood pressure monitoring (ABPM) and cardiac outcomes in children and young people (CYP) initiating dialysis.
Methods:
This is a retrospective, longitudinal study of CYP age 5-18 with paired echocardiogram and ABPM evaluations over 12 months ("baseline" to "follow-up") following dialysis initiation. Left ventricular hypertrophy (LVH) was defined by age-specific indexed left ventricular mass (LVMI) and LV mass-for-height z-score ≥ 95th percentile. Hypertension was defined if day, night, or 24-h ABPM ≥ 95th percentile and CYP was categorised as having persistent hypertension, resolved hypertension, persistent normotension, or emergent hypertension.
Results:
There were 32 CYP, with a mean age of 12.7 ± 3.1 years. LVH was present in 37.5% at baseline and 25% at follow-up. LVH rates improved on haemodialysis (baseline 52.9%, follow-up 17.6%, P = 0.031), but not on peritoneal dialysis. Higher rates of hypertension were found in LVH versus no LVH at follow-up. Masked hypertension rates was present in 14 (43.8%) at both baseline and follow-up. Mean LVMI was higher in persistently hypertensive versus persistently normotensive CYP at follow-up. ΔLVMI was independently associated with LVH at baseline (yes/no) (β = -0.482, P = 0.001), and Δlog N-terminal pro-brain b-type natriuretic peptide (NT Pro-BNP) (β = 0.412, P = 0.005).
Conclusions:
CYP with persistent hypertension had worst rates of LVH and indexed LV mass. A correlation between changes in NT Pro-BNP and LVMI highlights a probable role of fluid overload. Further research into using NT Pro-BNP as a biomarker to improve hypertension management is warranted.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension I: Introduction
